Cleared Traditional

Strados Remote Electronic Stethoscope Platform (RESP) (K220893) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220893 · Strados Labs, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
30d
Days
Class 2
Risk

K220893 is an FDA 510(k) clearance for the Strados Remote Electronic Stethoscope Platform (RESP). Classified as Recorder, Magnetic Tape, Medical (product code DSH), Class II - Special Controls.

Submitted by Strados Labs, Inc. (Philadelphia, US). The FDA issued a Cleared decision on April 27, 2022 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2800 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Strados Labs, Inc. devices

Submission Details

510(k) Number K220893 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2022
Decision Date April 27, 2022
Days to Decision 30 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 140d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DSH Recorder, Magnetic Tape, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Prithul Bom

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DSH Recorder, Magnetic Tape, Medical

All 35
Devices cleared under the same product code (DSH) and FDA review panel - the closest regulatory comparables to K220893.
eWave Monitor
K214073 · Wearlinq, Inc. · Oct 2022
AT-Patch ECG Analysis System
K203638 · Atsens Co., Ltd. · Oct 2022
QOCA Portable ECG Monitoring Device
K210179 · Quanta Computer, Inc. · Aug 2022
LifeLens Wireless ECG Monitor
K203168 · LifeLens Technologies, Inc. · Jul 2021
Zio Monitor
K202359 · iRhythm Technologies, Inc. · May 2021
QardioCore
K201644 · Qardio, Inc. · Feb 2021